Open access · US-GOV
via ClinicalTrials.gov Clinical trial
An Early Exploratory Clinical Trial to Evaluate CG-BM1 Allogeneic Human Bone Marrow Mesenchymal Stem Cell Injection in the Treatment of Sarcopenia
Authors not listed
GuangZhou Cellgenes Biotechnology Co., Ltd. · 2026
Abstract
1. To evaluate the safety and tolerability of CG-BM1 for the treatment of patients with Sarcopenia.
2. To observe the preliminary effectiveness of CG-BM1 in treating Sarcopenia patients.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-04 MST
Cite this
APA
Anonymous. (2026). An Early Exploratory Clinical Trial to Evaluate CG-BM1 Allogeneic Human Bone Marrow Mesenchymal Stem Cell Injection in the Treatment of Sarcopenia. <em>GuangZhou Cellgenes Biotechnology Co., Ltd.</em>. https://clinicaltrials.gov/study/NCT07865676
Vancouver
Anonymous. An Early Exploratory Clinical Trial to Evaluate CG-BM1 Allogeneic Human Bone Marrow Mesenchymal Stem Cell Injection in the Treatment of Sarcopenia. GuangZhou Cellgenes Biotechnology Co., Ltd.. 2026.
BibTeX
@misc{anon2026AnEarl,
title = {An Early Exploratory Clinical Trial to Evaluate CG-BM1 Allogeneic Human Bone Marrow Mesenchymal Stem Cell Injection in the Treatment of Sarcopenia},
author = {Anonymous},
journal = {GuangZhou Cellgenes Biotechnology Co., Ltd.},
year = {2026},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Longeveron Inc. 2014
Open access · US-GOV
A Phase I/II, Randomized, Blinded and Placebo-controlled Trial to Evaluate the Safety and Potential Efficacy of Allogeneic Human Mesenchymal Stem Cell Infusion in Patients With Aging Frailty
ENCell 2027
Open access · US-GOV
A Multi-center, Randomized, Double-blind, Placebo-controlled, Phase 1/2 Clinical Trial to Evaluate the Efficacy and Safety of EN001 in Patients With Sarcopenia
Experimental Gerontology 2006
Citation only
Skeletal muscle apoptosis, sarcopenia and frailty at old age
Merck Sharp & Dohme LLC 2007
Open access · US-GOV
A Phase IIa Randomized, Placebo-Controlled Clinical Trial to Study the Efficacy and Safety of MK-0773 in Patients With Sarcopenia
Free Radical Biology and Medicine 2018
Preprint · CC-BY
Sarcopenia, frailty and their prevention by exercise
CHABiotech CO., Ltd 2012
Open access · US-GOV